Medicare AdvantageCoverageHigh impact
Injections for Chronic Pain Conditions - Medicare Advantage (Revised)
Humana·Pain Management, Orthopedics, Neurology +2 more·Medicare Advantage
Effective date
Aug 3, 2026
We identified it
Aug 4, 2026
Summary
This is a comprehensive Medicare Advantage policy update for injections used in chronic pain management, effective 08/03/2026. The policy covers epidural steroid injections, facet joint injections, sacroiliac joint injections, trigger point injections, nerve blocks, and related procedures. Billing teams must verify compliance with regional Medicare Administrative Contractor (MAC) requirements, as coverage rules vary significantly by geographic jurisdiction.
Action Required
By 07/14/2026 (policy review date): Billing team must conduct a comprehensive audit of pain management injection billing procedures. (1) Identify which MAC jurisdiction(s) serve your patient population using the jurisdiction table (J5, J6, J8, J15, JE, JF, JH, JL, JJ, JM, or JN). (2) Cross-reference your practice's current billing codes and procedures against the applicable MAC-specific Local Coverage Determinations (LCDs) listed in the policy—coverage varies by MAC, and what is covered under one MAC may not be covered under another. (3) Update billing software, prior authorization workflows, and provider documentation requirements to reflect MAC-specific coverage limitations. (4) Train billing staff and providers on the distinction between diagnostic injections (which may have different authorization requirements) and therapeutic injections. (5) For each injection type (epidural, facet, sacroiliac, trigger point, nerve block), confirm that your current authorization, coding, and compliance processes align with the specific LCD for your geographic region. Failure to comply with MAC-specific requirements will result in claim denials and payment recoupment. This policy supersedes any prior Humana pain management injection policies.